Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Ryusuke Nakamoto"'
Publikováno v:
Clinical Nuclear Medicine; Jul2024, Vol. 49 Issue 7, pe359-e361, 3p
Autor:
Stephen E. Moore, Jennifer R. Eads, Carina Mari Aparici, Hwan Lee, Ryusuke Nakamoto, Daniel A. Pryma, Austin R. Pantel
Publikováno v:
Academic Radiology. 29:1308-1316
Rationale and Objectives High-grade gastroenteropancreatic neuroendocrine neoplasms (G3 GEP-NENs) are pathologically classified into well differentiated neuroendocrine tumors (G3 NETs) and poorly differentiated neuroendocrine carcinomas (G3 NECs). Us
Purpose To develop a convolutional neural network (CNN)-based program to analyse maximum intensity projection (MIP) images of 2-deoxy-2-[F-18]fluoro-d-glucose (FDG) positron emission tomography (PET) scans, aimed at predicting lymph node metastasis o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a64d479f1c0d6989a629648edc3bc9ba
https://doi.org/10.21203/rs.3.rs-2902943/v1
https://doi.org/10.21203/rs.3.rs-2902943/v1
Autor:
Walter G. Park, Rowaid Kellow, Bin Shen, Sanjiv S. Gambhir, Richard H. Kimura, Mahima Goel, Tom Haywood, Ryusuke Nakamoto, Valentina Ferri, Jarrett Rosenberg, Heying Duan, Negin Hatami, Mirwais Wardak, Andrei Iagaru
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 50:184-193
A novel cystine-knot peptide–based PET radiopharmaceutical, 18F-FP-R01-MG-F2 (knottin), was developed to selectively bind to human integrin αvβ6 which is overexpressed in pancreatic cancer. The purpose of this study is to evaluate the safety, bio
Publikováno v:
Clinical Nuclear Medicine; Dec2024, Vol. 49 Issue 12, p1148-1149, 2p
Publikováno v:
Clinical Nuclear Medicine; Nov2024, Vol. 49 Issue 11, p1053-1054, 2p
Autor:
Sunil Reddy, Benjamin L. Franc, Lisa C. Zaba, Farshad Moradi, Carina Mari Aparici, Guido Davidzon, Ryusuke Nakamoto, Tie Liang, Judy Nguyen, Andrei Iagaru
Publikováno v:
Journal of Nuclear Medicine. 62:1380-1383
Purpose: To investigate the prognostic value of 18F-FDG PET/CT parameters in melanoma patients before beginning anti-PD-1 therapy. Methods: Imaging parameters including SUVmax, metabolic tumor volume (MTV), and bone marrow to liver SUVmean ratio (BLR
Autor:
Andrei Iagaru, Guido Davidzon, Ryusuke Nakamoto, Judy Nguyen, Kip Guja, Farshad Moradi, Carina Mari Aparici, Hong Song, Benjamin L. Franc, Caitlyn Harrison, Negin Hatami
Publikováno v:
Molecular Imaging and Biology. 23:614-623
To evaluate the diagnostic performance and clinical utility of 18F-fluciclovine PET/CT in patients with biochemical recurrence (BCR) of prostate cancer (PC). 18F-Fluciclovine scans of 165 consecutive men with BCR after primary definitive treatment wi
Autor:
Jarrett Rosenberg, Sunil Reddy, Judy Nguyen, Benjamin L. Franc, Valentina Ferri, Lisa C. Zaba, Andrei Iagaru, Farshad Moradi, Guido Davidzon, Carina Mari Aparici, Tomomi Nobashi, Ryusuke Nakamoto
Publikováno v:
Molecular Imaging and Biology. 23:139-147
We investigated the ability of baseline 2-deoxy-2-[18F]fluoro-d-glucose PET/CT parameters, acquired before the start of immunotherapy, to predict development of hyperprogressive disease (HPD) in melanoma patients. We also evaluated the diagnostic per
Autor:
Ryusuke Nakamoto, Jialin Zhuo, Kip E. Guja, Heying Duan, Stephanie L. Perkins, Christoph Leuze, Bruce L. Daniel, Benjamin Lewis Franc
Publikováno v:
Oral oncology. 125
To show that augmented reality (AR) visualization of single-photon emission computed tomography (SPECT)/computed tomography (CT) data in 3D can be used to accurately localize targets in the head and neck region.Eight head and neck styrofoam phantoms